Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Linear Formula:
(CH3)4N(OCOCH3)
CAS Number:
Molecular Weight:
133.19
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352116
EC Number:
234-179-3
MDL number:
Beilstein/REAXYS Number:
3571830
Product Name
Tetramethylammonium acetate, ≥97%
InChI key
MRYQZMHVZZSQRT-UHFFFAOYSA-M
InChI
1S/C4H12N.C2H4O2/c1-5(2,3)4;1-2(3)4/h1-4H3;1H3,(H,3,4)/q+1;/p-1
SMILES string
CC([O-])=O.C[N+](C)(C)C
assay
≥97%
form
solid
mp
184 °C (dec.) (lit.)
Quality Level
Looking for similar products? Visit Product Comparison Guide
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Zhiyuan Zhao et al.
ACS omega, 5(30), 19247-19254 (2020-08-11)
In this work, poly(ethylene terephthalate) (PET) chain-extending products with different molecular weights were prepared by reactive extrusion using isocyanate trimer (C-HK) as the trifunctional chain extender. The effect of the chain extender C-HK on the intrinsic viscosity, melt flow property
Mesude Bicak et al.
Proceedings of the National Academy of Sciences of the United States of America, 117(26), 15172-15181 (2020-06-14)
Hu11B6 is a monoclonal antibody that internalizes in cells expressing androgen receptor (AR)-regulated prostate-specific enzyme human kallikrein-related peptidase 2 (hK2; KLK2). In multiple rodent models, Actinium-225-labeled hu11B6-IgG1 ([225Ac]hu11B6-IgG1) has shown promising treatment efficacy. In the present study, we investigated options
Daniel L J Thorek et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 25(2), 881-891 (2018-09-27)
The impact of androgen receptor (AR) activity in breast cancer biology is unclear. We characterized and tested a novel therapy to an AR-governed target in breast cancer.Experimental Design: We evaluated the expression of prototypical AR gene products human kallikrein 2
Aleksandra M Urbanska et al.
Cancer biotherapy & radiopharmaceuticals, 35(6), 459-473 (2020-02-06)
An α particle-emitting nanodrug that is a potent and specific antitumor agent and also prompts significant remodeling of local immunity in the tumor microenvironment (TME) has been developed and may impact the treatment of melanoma. Biocompatible ultrasmall fluorescent core-shell silica
Alexey A Nazarov et al.
Dalton transactions (Cambridge, England : 2003), 44(8), 3614-3623 (2014-11-20)
Chemotherapeutics for the treatment of tumorigenic conditions that feature novel modes of action are highly sought after to overcome the limitations of current chemotherapies. Herein, we report the conjugation of the alkylating agent chlorambucil to the RAPTA scaffold, a well-established
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service